Osteoporosis, often referred to as the “silent disease,” poses significant health risks for older adults, particularly women. This condition leads to weakened bones and...
The treatment landscape for indolent systemic mastocytosis (ISM) is evolving, with new therapies and research shedding light on potential improvements in patient outcomes. Clinical...